endocrinology-diabetes-summit-2019-keynote

2 / 8

Page 13
Notes:
allied
academies
Journal of Diabetology | Volume 3
Annual Summit on
Diabetes, Obesity & Heart
Diabetes, Endocrinology and Metabolic Syndrome
International Conference on
Joint Event
&
March 07-08, 2019 | London, UK
Diabetic eye disorders have been of common occurrence
resulting from a progressive uncontrolled disease
leading to cataracts and retinopathy. A review of past
literature from 2006 to date has demonstrated a common
message i.e. utilizations of vitamins for the resolutions of
retinal disorders. The researchers in 2006 had shown the
effects of retinol as an agent in the treatment of age-related
maculopathy. Subsequent studies were focused on Vitamin A
supplementation in children for Retinal dysfunction. Our
current research from 2015 had one primary objective
of creating a topical preparation as an alternative to the
oral treatment to escape from systemic side effects. The
OPTICORR our innovative formulation was studied in the
pilot project and had shown a dramatic improvement
restoring to normal vision. The patients were instructed to
apply OPTICORR on the eyelids externally for a duration of 12
weeks. A large scale study has been conducted with a target
population of 30 patients. The project will be continued for
an in determined period due to the encouraging benefits for
a duration to normal restoration. In addition, the medication
has shown resolution of challenging dermatological diseases.
The study was free of any adverse symptoms except for
presence of l erythema at the region of the application on the
skin would likely indicate intolerance to vitamin ingredients
therefore a discontinuation would be warranted.
Speaker Biography
Vinod Chandra Tawar has earned BSc Hons. and BSc Tech. Pharmaceuticals from
University of Bombay. He was offered a teaching assistantship at the School of
Pharmacy, University of Manitoba, Canada, where he achieved a Post-graduate
(MSc) degree in Pharmacology followed by working as a Toxicologist at a University
Hospital in Winnipeg for a duration of 10 years. In due course, he developed a
Toxicology laboratory for patient management and Forensic purposes. This later
became a reference laboratory for the Province of Manitoba. In 1981, he decided to
study Medicine and graduated Medicine in 1985. Subsequently, he joined Douglas
Hospital Research Centre at McGill University as a Psychiatry Research Consultant
with participation in projects on depression, Alzheimer’s disease, alcoholism and
schizophrenia. Currently he is working in King George Medical Clinic, Canada.
e:
Vinod Chandra Tawar
King George Medical Clinic, Canada
Diabetic eye disorders and a novel approach via “OPTICORR”